Serum Institute to focus on supplying COVID-19 vaccine to India first

Poonawalla's comments came shortly after AstraZeneca said on Monday its vaccine could be around 90% effective, giving the world's fight against the pandemic a new weapon, cheaper to make, easier to distribute and faster to scale up than rivals.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news